The clinical relevance of these observations is underscored by experimental work indicating that the genetic deletion of PAI-1 in the brain of a murine model of AD reduces the deposition of Aβ by increasing tPA-induced plasmin-mediated cleavage of Aβ-containing plaques [164]. This evidence concerns the gene PLG and Alzheimer disease.